Stem cells for the treatment of heart failure

Current Opinion in Molecular Therapeutics

Volumn 12, Issue 4, 2010, Pages 432-441

  Kearns Jonker, M ^a   Dai, W ^b   Kloner, Robert A ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD133 ANTIGEN; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGENASE; CYCLOSPORIN A; DISPASE; ENDOGLIN; FLT3 LIGAND; MATRIGEL; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MULTIDRUG RESISTANCE PROTEIN 1; MYOCYTE ENHANCER FACTOR 2; MYOSIN HEAVY CHAIN ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PINACIDIL; PROTEIN BCL 2; SCATTER FACTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR GATA 4; TRYPSIN; UNINDEXED DRUG; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL MODEL; APOPTOSIS; BLOOD; BONE MARROW; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL REGENERATION; CELL SURVIVAL; DRUG EFFICACY; EMBRYONIC STEM CELL; HEART; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; RODENT; SAFETY; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL; SWINE; ANIMAL; CYTOLOGY; DRUG SCREENING; HEART MUSCLE; METABOLISM; PATHOLOGY;

ANIMALS; BIOLOGICAL MARKERS; DRUG EVALUATION, PRECLINICAL; HEART FAILURE; HUMANS; MYOCARDIUM; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77955408812     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. S un L, Zhang T, Lan X, Du G: Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: A meta-analysis. Clin Cardiol (2010) 33(5):296-302.
2. Wöhrle J, Merkle N, Mailander V, Nusser T, Schauwecker P, von Scheidt F, Schwarz K, Bommer M, Wiesneth M, Schrezenmeier H, Hombach V: Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol (2010) 105(6):804-812.
3. Wollert KC, Drexler H: Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol (2010) 7(4):204-215.
4. The International Stem Cell Banking Initiative: Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev (2009) 5(4):301-314.
5. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, Muskheli V, Nourse MB, Bendixen K, Reinecke H, Murry CE: Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA (2009) 106(39):16568-16573.
6. Dai W, Hale SL, Kay GL, Jyrala AJ, Kloner RA: Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med (2009) 4(3):387-395.
7. Van Hoof D, Dormeyer W, Braam SR, Passier R, Monshouwer-Kloots J, Ward-van Oostwaard D, Heck AJ, Krijgsveld J, Mummery CL: Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res (2010) 9(3): 1610-1618.
8. Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K, et al.: Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2010) 7(1):61-66.
9. van Vliet P, Smits AM, de Boer TP, Korfage TH, Metz CH, Roccio M, van der Heyden MA, van Veen TA, Sluijter JP, Doevendans PA, Goumans MJ: Foetal and adult cardiomyocyte progenitor cells have different developmental potential. J Cell Mol Med (2010) 14(4):861-870.
10. Zaruba MM, Soonpaa M, Reuter S, Field LJ: Cardiomyogenic potential of c-Kit+-expressing cells derived from neonatal and adult mouse hearts. Circulation (2010) 121(18):1992-2000.
11. Yi BA, Wernet O, Chien KR: Pregenerative medicine: Developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest (2010) 120(1):20-28.
12. Boudoulas KD, Hatzopoulos AK: Cardiac repair and regeneration: The Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 2(7-8):344-458.
13. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B: Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med (2007) 167(10):989-997.
14. Segers VF, Lee RT: Stem cell therapy for cardiac disease. Nature (2008) 451(7181):937-942.
15. Yamada Y, Wang XD, Yokoyama S, Fukuda N, Takakura N: Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. Biochem Biophys Res Commun (2006) 342(2): 662-670.
16. Liu Z, Wang H, Zhang Y, Zhou J, Lin Q, Wang Y, Duan C, Wu K, Wang C: Efficient isolation of cardiac stem cells from brown adipose tissue. J Biomed Biotechnol (2010):104-296.
17. Jumabay M, Matsumoto T, Yokoyama S, Kano K, Kusumi Y, Masuko T, Mitsumata M, Saito S, Hirayama A, Mugishima H, Fukuda N: Dedifferentiated fat cells convert to cardiomyocyte phenotype and repair infarcted cardiac tissue in rats. Mol Cell Cardiol (2009) 47(5):565-575.
18. De Siena R, Balducci L, Blasi A, Montanaro MG, Saldarelli M, Saponaro V, Martino C, Logrieco G, Soleti A, Fiobellot S, Madeddu P, et al.: Omentum-derived stromal cells improve myocardial regeneration in pig post-infarcted heart through a potent paracrine mechanism. Exp Cell Res (2010) 316(11): 1804-1815.
19. Schipper BM, Marra KG, Zhang W, Donnenberg AD, Rubin JP: Regional anatomic and age effects on cell function of human adiposederived stem cells. Ann Plast Surg (2008) 60(5):538-544.
20. Choi YS, Dusting GJ, Stubbs S, Arunothayaraj S, Han XL, Collas P, Morrison WA, Dilley RJ: Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med (2010) 14(4):878-889.
21. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K, Li TS, White A, Makkar R, Marbán E: Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One (2009) 4(9):e7195.
22. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, et al.: Human cardiac stem cells. Proc Natl Acad Sci USA (2007) 104(35):14068-14073.
23. Smits AM, van Laake LW, den Ouden K, Schreurs C, Szuhai K, van Echteld CJ, Mummery CL, Doevendans PA, Goumans MJ: Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc Res (2009) 83(3):527-535.
24. Grinnemo KH, Kumagai-Braesch M, Mnsson-Broberg A, Skottman H, Hao X, Siddiqui A, Andersson A, Strömberg AM, Lahesmaa R, Hovatta O, Sylven C, et al.: Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online (2006) 13(5):712-724.
25. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marbán E: Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res (2010) 106(5):971-980.
26. Itzhaki-Alfia A, Leor J, Raanani E, Sternik L, Spiegelstein D, Netser S, Holbova R, Pevsner-Fischer M, Lavee J, Barbash IM: Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation (2009) 120(25):2559-2566.
27. Amir G, Ma X, Reddy VM, Hanley FL, Reinhartz O, Ramamoorthy C, Riemer RK: Dynamics of human myocardial progenitor cell populations in the neonatal period. Ann Thorac Surg (2008) 86(4):1311-1319.
28. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, et al.: Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature (2005) 433(7026):647-653.
29. Kubo H, Jaleel N, Kumarapeli A, Berretta RM, Bratinov G, Shan X, Wang H, Houser SR, Margulies KB: Increased cardiac myocyte progenitors in failing human hearts. Circulation (2008) 118(6):649-657.
30. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short-and long-term effects. Circulation (2005) 112(2):214-223.
31. Anderson CD, Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Jordan MC, Kim JK, Brown DA, Zuk PA, Laks H, Roos KP, Maclellan WR, et al.: The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury. J Surg Res (2008) 148(2):164-171.
32. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, et al.: Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol (2007) 25(9):1015-1024.
33. Madonna R, Rokosh G, De Caterina R, Bolli R: Hepatocyte growth factor/Met gene transfer in cardiac stem cells-Potential for cardiac repair. Basic Res Cardiol (2010) 105(4):443-452.
34. Tang J, Wang J, Song H, Huang Y, Yang J, Kong X, Guo L, Zheng F, Zhang L: Adenovirus-mediated stromal cell-derived factor-1 α gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep (2010) 37(4):1957-1969.
35. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T: Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation (2003) 107(9): 1322-1328.
36. Lataillade JJ, Clay D, Bourin P, Hérodin F, Dupuy C, Jasmin C, Le Bousse-Kerdils MC: Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: Evidence for an autocrine/paracrine mechanism. Blood (2002) 99(4):1117-1129.
37. Yin Q, Jin P, Liu X, Wei H, Lin X, Chi C, Liu Y, Sun C, Wei Y: SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep (2010):doi:10.1007/s11033-010-0071-79
38. Sanganalmath SK, Stein AB, Guo Y, Tiwari S, Hunt G, Vincent RJ, Huang Y, Rezazadeh A, Ildstad ST, Dawn B, Bolli R: The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up. J Mol Cell Cardiol (2009) 47(4):528-535.
39. Kutschka I, Kofidis T, Chen IY, von Degenfeld G, Zwierzchoniewska M, Hoyt G, Arai T, Lebl DR, Hendry SL, Sheikh AY, Cooke DT, et al.: Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation (2006) 114(1 Suppl): I174-I180.
40. Oh SH, Miyazaki M, Kouchi H, Inoue Y, Sakaguchi M, Tsuji T, Shima N, Higashio K, Namba M: Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro. Biochem Biophys Res Commun (2000) 279(2):500-504.
41. Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, Fiaccavento R, Carotenuto F, De Vito P, Baldini PM, Prat M, et al.: Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells (2006) 24(1):23-33.
42. R oggia C, Ukena C, Böhm M, Kilter H: Hepatocyte growth factor (HGF) enhances cardiac commitment of differentiating embryonic stem cells by activating PI3 kinase. Exp Cell Res (2007) 313(5):921-930.
43. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI: Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol (2005) 46(7):1339-1350.
44. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, et al.: Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation (2010) 121(17):1912-1925.
45. Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, Chau LY: Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol (2008) 45(1):44-55.
46. Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, et al.: Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 121(2):293-305.
47. Hale SL, Dai W, Dow JS, Kloner RA: Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: A quantitative assessment. Life Sci (2008) 83(13-14):511-515
48. Wang X, Jameel MN, Li Q, Mansoor A, Qiang X, Swingen C, Panetta C, Zhang J: Stem cells for myocardial repair with use of a transarterial catheter. Circulation (2009) 120(11 Suppl):S238-S246.
49. Coutu DL, Yousefi AM, Galipeau J: Three-dimensional porous scaffolds at the crossroads of tissue engineering and cellbased gene therapy. J Cell Biochem (2009) 108(3):537-546.
50. Curtis MW, Russell B: Cardiac tissue engineering. J Cardiovasc Nurs (2009) 24(2):87-92.
51. Gálvez BG, Covarello D, Tolorenzi R, Brunelli S, Dellavalle A, Crippa S, Mohammed SA, Scialla L, Cuccovillo I, Molla F, Staszewsky L, et al.: Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. Cardiovasc Res (2009) 83(4):707-716.
52. Asai Y, Tada M, Otsuji TG, Nakatsuji N: Combination of functional cardiomyocytes derived from human stem cells and a highlyefficient microelectrode array system: An ideal hybrid model assay for drug development. Curr Stem Cell Res Ther (2010) 5(3):227-232.
53. Segers VF, Lee RT: Stem cell therapy for cardiac disease. Nature (2008) 451(7181):937-942.
54. Mummery C, Davis R and Krieger J: Challenges in using stem cells for cardiac repair. Sci Transl Med (2010) 2(27):27ps17.
55. Johnston PV, Sasano T, Mills K, Evers R, Lee ST, Smith RR, Lardo AC, Lai S, Steenbergen C, Gerstenblith G, Lange R, et al.: Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation (2009) 120(12):1075-1083.
56. Dai W, Field LJ, Rubart M, Reuter S, Hale SL, Zweigerdt R, Graichen RE, Kay GL, Jyrala AJ, Colman A, Davidson BP, et al.: Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 43(4): 504-516.
57. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, et al.: Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature (2008) 453(7194):524-528.
58. Adler ED, Chen VC, Bystrup A, Kaplan AD, Giovannone S, Briley-Saebo K, Young W, Kattman S, Mani V, Laflamme M, Zhu WZ, et al.: The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction. FASEB J (2010) 24(4):1073-1081.
59. van Laake LW, van Donselaar EG, Monshouwer-Kloots J, Schreurs C, Passier R, Humbel BM, Doevendans PA, Sonnenberg A, Verkleij AJ, Mummery CL: Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cell Mol Life Sci (2010) 67(2):277-290.
60. Nourse MB, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, Torok-Storb B, Ratner BD, Pabon L, Murry CE: VEGF induces differentiation of functional endothelium from human embryonic stem cells: Implications for tissue engineering. Arterioscler Thromb Vasc Biol (2010) 30(1):80-89.
61. Xue T, Cho HC, Akar FG, Tsang SY, Jones SP, Marbán E, Tomaselli GF, Li RA: Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: Insights into the development of cell-based pacemakers. Circulation (2005) 111(1):11-20.
62. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L: Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation (2009) 120(15):1513-1523.
63. Freund C, Davis RP, Gkatzis K, Ward-van Oostwaard D, Mummery CL: The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J (2010) 18(1):51-54.
64. Germanguz I, Sedan O, Zeevi-Levin N, Shtreichman R, Barak E, Ziskind A, Eliyahu S, Meiry G, Amit M, Itskovitz-Eldor J, Binah O: Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med (2010):doi:10.1111/j.1582-4934. 2009.00996.
65. Pera MF: Stem cells: Low-risk reprogramming. Nature (2009) 458(7239):715-716.
66. Chang CW, Lai YS, Pawlik KM, Liu K, Sun CW, Li C, Schoeb TR, Townes TM: Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells (2009) 27(5):1042-1049.
67. Hotta A, Cheung AY, Farra N, Garcha K, Chang WY, Pasceri P, Stanford WL, Ellis J: EOS lentiviral vector selection system for human induced pluripotent stem cells. Nat Protoc (2009) 4(12):1828-1844.
68. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, et al.: Bone marrow cells regenerate infarcted myocardium. Nature (2001) 410(6829):701-705.
69. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, et al.: Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 428(6983):664-668.
70. Nygren JM, Jovinge S, Breitbach M, Säwén P, Röll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE: Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med (2004) 10(5):494-501.
71. Koninckx R, Hensen K, Daniëls A, Moreels M, Lambrichts I, Jongen H, Clijsters C, Mees U, Steels P, Hendrikx M, Rummens JL: Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy (2009) 11(6):778-792.
72. Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, Zamini S, Khorsand A, Sochor H, Maurer G, Glogar D, et al.: Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost (2010) 103(3):564-571.
73. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J, Maertens J, et al.: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet (2006) 367(9505):113-121.
74. Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, et al.: Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail (2010) 3(1):89-96.
75. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, et al.: The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebocontrolled study of myoblast transplantation. Circulation (2008) 117(9):1189-1200.
76. Menasché P: Stem cell therapy for heart failure: Are arrhythmias a real safety concern? Circulation (2009) 119(20): 2735-2740.